Publications

Katona MA, Long TF, Kirman CR, Gargas ML, Rish WR. Derivation of a cancer potency factor and dermal absorption factor for benzo(a)pyrene. Toxicologist 54, Abstract 873. Presented at Society of Toxicology 39th Annual Meeting, Philadelphia, PA, March 2000.

Thomas MJ, Robison TW, Forman HJ. 2000. Assessment of tissue injury from reactive oxygen metabolites. In: Chronic Lung Disease in Early Infancy. R.D. Bland and J.J. Coalson, eds. Marcel Dekker, Inc., New York. pp. 779-792.

Clewell HJ III, Gentry PR, Allen BC, Covington TR, Gearhart JM. 2000. Development of a physiologically-based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment. Environ Health Perspect 108(Suppl 2):283–305; doi: 10.1289/ehp.00108s2283. PMID: 10807559.

Jankowski-Hennig MA, Clegg MS, Daston GP, Rogers JM, Keen CL. 2000. Zinc-deficient rat embryos have increased caspase 3-like activity and apoptosis. Biochem Biophys Res Commun 271(1):250–256; doi: 10.1006/bbrc.2000.2608. PMID: 10777711.

Lau C, Anderson ME, Crawford-Brown DJ, Kavlock RJ, Kimmel CA, Knudsen TB, Muneoka K, Rogers JM, Setzer RW, Smith G, Tyl R. 2000. Evaluation of biologically based dose-response modeling for developmental toxicity: A workshop report. Regul Toxicol Pharmacol 31(2 Pt 1):190–199; 10.1006/rtph.1999.1360. PMID: 10854125.

Gentry R, Clewell H, Covington T, Wilson J. Investigation of the impact of benchmark and PBPK modeling on the derivation of MRLs. Poster presented at Society of Toxicology 39th Annual Meeting, Philadelphia, PA, March 2000.

Clewell HJ, Gentry PR, Gearhart JM, Born SL, Lehman-McKeeman LD, Covington TR. Development of a physiologically-based pharmacokinetic (PB-PK) model and human health risk assessment for coumarin. Poster presented at Society of Toxicology 39th Annual Meeting, Philadelphia, PA, March 2000.

Kelsh MA, Kheifets LI, Smith RW. 2000. The impact of work environment, utility and sampling design on occupational exposure summaries. AIHA J 61(2):174–182; doi: 10.1080/15298660008984526. PMID: 10782189.

Morgan RW, Kelsh MA, Zhao K, Exuzides KA, Heringer S, Negrete W. 2000. Radiofrequency exposure and mortality from cancers of the brain and lymphatic/hematopoietic system. Epidemiol 11(2):118–127; doi: 10.1097/00001648-200003000-00007. PMID: 11021607.

Bartoe JT, Albrecht B, Collins ND, Robek MD, Ratner L, Green PL, Lairmore MD. 2000. Functional role of pX open reading frame II of human T-lymphotropic virus type 1 in maintenance of viral loads in vivo. J Virol 74(3):1094–1100; doi: 10.1128/jvi.74.3.1094-1100.2000. PMID: 10627519.

Frankenfeld C, Taren D. 2000. HIV and infant growth. In: Watson R (ed), Nutrition and AIDS, 2nd edition. CRC Press, Boca Raton, Florida, ISBN: 97881420042290.

Choksi NY, Nix WB, Wyrick SD, Booth RG. 2000. A novel phenylaminotetralin (PAT) recognizes histamine H1 receptors and stimulates dopamine synthesis in vivo in rat brain. Brain Res 852(1):151–160; doi: 10.1016/s0006-8993(99)02228-3. PMID: 10661506.

Choksi NY, Nix WB, Wyrick SD, Booth RG. Phenylaminotetralins activate histamine H1 receptors to stimulate dopamine synthesis in vivo in rat brain. Poster presented at the Receptor Chemistry Towards the Third Millennium – 12th Camerino-Noordwijkerhout Symposium, 1999.

Haws L. Permitting of hazardous waste combustion facilities in the state of Texas: Risk assessment procedures and status update. Presented at the Texas Chemical Council Quarterly Meeting. Houston, TX, September 1999.

Collins ND, D’Souza C, Albrecht B, Robek MD, Ratner L, Ding W, Green PL, Lairmore MD. 1999. Proliferation response to interleukin-2 and Jak/Stat activation of T cells immortalized by human T-cell lymphotropic virus type 1 is independent of open reading frame I expression. J Virol 73(11):9642–9649; doi:  10.1128/JVI.73.11.9642-9649.1999. PMID: 10516077.

Cher DJ, Mrad RJ, Kelsh MA. 1999. Cellular telephone use and fatal traffic collisions: A commentary. Accid Anal Prev 31(5):599; doi: 10.1016/s0001-4575(99)00003-2. PMID: 10440557.

Clewell HJ, Gearhart JM, Gentry PR, Covington TR, Van Landingham CB, Crump KS, Shipp AM. 1999. Evaluation of the uncertainty in an oral reference dose for methylmercury due to interindividual variability in pharmacokinetics. Risk Anal 19(4):547–558; doi: 10.1111/j.1539-6924.1999.tb00427.x. PMID: 10765421.

Rish W, Kirman CR, Hays SM, Gargas ML, Andersen ME, Reitz RH, Guengerich FP, Green T, McConnell EE, Buckpit A, Voytek P, Dugard PH. 1999. Developing a physiologically based pharmacokinetic model to describe methylene chloride kinetics at the subcellular level. Toxicologist 48, Paper No. 671. Presented at Society of Toxicology 38th Annual Meeting, New Orleans, LA, March 1999.

Cyr PL, Malloy D. 1999. Patient satisfaction and physician profiling. In: Lynman K, Piland N (eds) Physician Profiling: A Source Book for Health Care Administrators. Jossey-Bass Health Series, San Francisco. pp. 121-136.

Trippodo NC, Fox M, Monticello TM, Panchal BC, Asaad MM. 1999. Vasopeptidase inhibition with omapatrilat improves cardiac geometry and survival in cardiomyopathic hamsters more than does ACE inhibition with captopril. J Cardiovasc Pharmacol 34(6):782-790; doi: 10.1097/00005344-199912000-00003. PMID: 10598120.